Relation of coronary atherosclerosis determined by election beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (The Dallas Heart Study)

被引:72
作者
Abdullah, SM
Khera, A
Das, SR
Stanek, HG
Canham, RM
Chung, AK
Morrow, DA
Drazner, MH
McGuire, DK
de Lemos, JA
机构
[1] Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75216 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
D O I
10.1016/j.amjcard.2005.06.073
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated plasma levels of B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro-BNP) are seen in the setting of cardiac ischemia and are associated with adverse outcomes in patients with coronary artery disease. The mechanisms leading to natriuretic peptide elevation in patients with coronary artery disease, including the contribution of coronary atherosclerosis itself, have not been fully elucidated. Measurement of NT-pro-BNP, electron beam computed tomography, and cardiac magnetic resonance imaging were performed in 2,445 subjects from the Dallas Heart Study who were free of heart failure and renal insufficiency. Electron beam computed tomography- determined coronary artery calcium scores were categorized as none (< 10), mild ( 10 to < 100), moderate ( >= 100 to < 400), and severe ( >= 400). NT-pro-BNP levels increased significantly across increasing coronary artery calcium score categories (p < 0.0001 for trend). In multivariate models adjusted for age, gender, race, body mass index, hypertension, history of myocardial infarction, angina, angiotensin-converting enzyme inhibitor use, P-blocker use, left ventricular (LV) ejection fraction, and LV mass, higher coronary artery calcium scores remained independently associated with higher log NT-pro-BNP levels (p = 0.03). This association persisted in similar models excluding patients with low LV ejection fractions, LV hypertrophy, angina pectoris, and a history of myocardial infarction. In conclusion, these findings support the hypothesis that coronary atherosclerosis may directly influence the activation of the cardiac neurohormonal system. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1284 / 1289
页数:6
相关论文
共 30 条
  • [11] Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia
    He, ZX
    Hedrick, TD
    Pratt, CM
    Verani, MS
    Aquino, V
    Roberts, R
    Mahmarian, JJ
    [J]. CIRCULATION, 2000, 101 (03) : 244 - 251
  • [12] Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease - Enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion
    Hopkins, WE
    Chen, ZY
    Fukagawa, NK
    Hall, C
    Knot, HJ
    LeWinter, MM
    [J]. CIRCULATION, 2004, 109 (23) : 2872 - 2877
  • [13] African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas heart study
    Jain, T
    Peshock, R
    McGuire, DK
    Willett, D
    Yu, ZZ
    Vega, GL
    Guerra, R
    Hobbs, HH
    Grundy, SM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (05) : 1011 - 1017
  • [14] N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease
    Kragelund, C
    Gronning, B
    Kober, L
    Hildebrandt, P
    Steffensen, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (07) : 666 - 675
  • [15] Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging
    Lorenz, CH
    Walker, ES
    Morgan, VL
    Klein, SS
    Graham, TP
    [J]. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 1999, 1 (01) : 7 - 21
  • [16] Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarttion - B-Type natriuretic peptide and prognosis in TACTICS-TIMI 18
    Morrow, DA
    de Lemos, JA
    Sabatine, MS
    Murphy, SA
    Demopoulos, LA
    DiBattiste, PM
    McCabe, CH
    Gibson, CM
    Cannon, CP
    Braunwald, E
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (08) : 1264 - 1272
  • [17] Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function
    Nishikimi, T
    Mori, Y
    Ishimura, K
    Tadokoro, K
    Yagi, H
    Yabe, A
    Horinaka, S
    Matsuoka, H
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 116 (08) : 517 - 523
  • [18] N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes
    Omland, T
    Persson, A
    Ng, L
    O'Brien, R
    Karlsson, T
    Herlitz, J
    Hartford, M
    Caidahl, K
    [J]. CIRCULATION, 2002, 106 (23) : 2913 - 2918
  • [19] B-Type natriuretic peptide and long-term survival in patients with stable coronary artery disease
    Omland, T
    Richards, AM
    Wergeland, R
    Vik-Mo, H
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (01) : 24 - 28
  • [20] Usefulness of brain natriuretic peptide levels to discriminate patients with stable angina pectoris without and with electrocardiographic myocardial ischemia and patients with healed myocardial infarction
    Palumbo, B
    Siepi, D
    Lupattelli, G
    Sinzinger, H
    Fiorucci, G
    Anniboletti, PF
    Latini, RA
    Mannarino, E
    Palumbo, R
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (06) : 780 - 783